Chemoinformaics analysis of SYRINGETIN-3-O-RUTINOSIDE
| Molecular Weight | 654.574 | nRot | 8 |
| Heavy Atom Molecular Weight | 620.302 | nRig | 30 |
| Exact Molecular Weight | 654.18 | nRing | 5 |
| Solubility: LogS | -3.583 | nHRing | 3 |
| Solubility: LogP | -0.545 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 17 | APOL | 84.735 |
| nHD | 9 | BPOL | 47.129 |
| QED | 0.135 |
| Synth | 4.825 |
| Natural Product Likeliness | 1.891 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.995 |
| HIA | 0.94 |
| CACO-2 | -6.344 |
| MDCK | 0.0000546 |
| BBB | 0.168 |
| PPB | 0.745902 |
| VDSS | 0.672 |
| FU | 0.301935 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.077 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.309 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.184 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.006 |
| CL | 1.36 |
| T12 | 0.491 |
| hERG | 0.043 |
| Ames | 0.785 |
| ROA | 0.034 |
| SkinSen | 0.022 |
| Carcinogencity | 0.031 |
| EI | 0.006 |
| Respiratory | 0.021 |
| NR-Aromatase | 0.885 |
| Antiviral | Yes |
| Prediction | 0.753416 |